Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-23-009062
Filing Date
2023-03-22
Accepted
2023-03-22 09:56:25
Documents
15
Period of Report
2023-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A hypr-20230321.htm   iXBRL 8-K/A 58503
2 EX-99.1 hypr-ex99_1.htm EX-99 655459
3 GRAPHIC img66230450_0.jpg GRAPHIC 3773
4 GRAPHIC img66230450_1.jpg GRAPHIC 3773
  Complete submission text file 0000950170-23-009062.txt   871796

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hypr-20230321_pre.xml EX-101.PRE 10654
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hypr-20230321.xsd EX-101.SCH 2457
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hypr-20230321_lab.xml EX-101.LAB 14536
9 EXTRACTED XBRL INSTANCE DOCUMENT hypr-20230321_htm.xml XML 5067
Mailing Address 351 NEW WHITFIELD STREET GUILFORD CT 06437
Business Address 351 NEW WHITFIELD STREET GUILFORD CT 06437 866-796-6767
Hyperfine, Inc. (Filer) CIK: 0001833769 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39949 | Film No.: 23751648
SIC: 3845 Electromedical & Electrotherapeutic Apparatus